Evidence map›Paper›PMID 42601835›Full record

ArticleJournal of cellular and molecular medicine2026

An Ultrastructural and Proteomic Analysis in DM1 Young Adults' Myoblasts: Stressed RER and Mitochondrial Dysfunction Involvement.

Renata Del Carratore, Alessandra Falleni, Margherita Bernardeschi, Giada Frenzilli, Michela Ripolone, Sabrina Salani, Filippo Geraci, Fabiana Miraglia, Cristina Del Seppia

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Renata Del CarratoreInstitute of Clinical Physiology, National Research Council, Pisa, Italy.ORCID 0000-0002-7504-0379
Alessandra FalleniDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.ORCID 0000-0001-6492-6038
Margherita BernardeschiItalian Institute of Technology, Center for Materials Interfaces, Smart Bio-Interfaces, Pontedera, Italy.ORCID 0000-0003-2650-1834
Giada FrenzilliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.ORCID 0000-0003-1927-838X
Michela RipoloneNeuromuscular and Rare Disease Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0001-9293-6823
Sabrina SalaniNeurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0009-0006-3125-7740
Filippo GeraciInstitute for Informatics and Telematics, National Research Council, Pisa, Italy.ORCID 0000-0001-6993-6761
Fabiana MiragliaBio@SNS Laboratory, Scuola Normale Superiore, Pisa, Italy.ORCID 0000-0002-7103-668X
Cristina Del SeppiaInstitute of Clinical Physiology, National Research Council, Pisa, Italy.ORCID 0000-0001-7459-8680

Funding

Regione Toscana B5412000273002
6 · The paper itself

Abstract

Myotonic dystrophy type 1 (DM1) is a progressive muscular disorder caused by the expansion of CTG repeats in the 3' UTR of the DMPK gene. Although the pathogenic mechanisms remain unclear, recent evidence suggests that activation of innate immune responses may contribute to disease progression. In this study, we examined the ultrastructure and proteomic data of myoblasts from young adult DM1 patients carrying approximately 800 and 1300 CTG repeats in order to investigate a link between cellular stress and immune activation. We observed activation of the type I interferon (IFN-I) pathway associated with rough endoplasmic reticulum stress (sRER). The sRER response is likely triggered by the accumulation of toxic RNA species generated from the expanded DMPK allele. Our data suggest that this inappropriate activation of the IFN-I pathway contributes to muscle pathology, not by blocking differentiation directly, but through chronic stress signalling. These findings support a model in which innate immune dysregulation plays a central role in DM1 muscle degeneration and highlight the IFN1 pathway as a potential therapeutic target for restoring normal muscle function.

Indexed as

Endoplasmic Reticulum StressMitochondriaMyoblastsMyotonic DystrophyProteomicsAdultFemaleHumansInterferon Type IMaleMyotonin-Protein KinaseSignal TransductionTrinucleotide Repeat ExpansionYoung AdultDMPK protein, humanInterferon Type IMyotonin-Protein KinasedsRNAinterferon I signallingmitochondrial dysfunctionmyotonic dystrophy type 1proteomicsstressed RER

Identifiers

PMID42601835
PMCPMC13476700

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.